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Lipoxin A4 (LxA4) Promotes Reduction and Antibiotic
Efficacy Against Pseudomonas aeruginosa Biofilm
Julianne M. Thornton, Jean Walker, Prem Y. K. Sundarasivarao, Bernd Spur, Ana Rodriguez, Kingsley Yin
Rowan University School of Osteopathic Medicine, Stratford, NJ, USA

Abstract
Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic bacterium commonly found in wound
infections and airways of cystic fibrosis patients. P. aeruginosa readily forms biofilms which can reduce
the efficacy of antibiotics used to eradicate the pathogen. We have previously shown that a Specialized
Pro-resolving Mediator (SPM), Lipoxin A4 (LxA4) is a quorum sensing inhibitor which can reduce P.
aeruginosa virulence. In this study, we examined the direct actions of LxA4 and RvD2 on P. aeruginosa
biofilm formation and virulence gene expression. The influence of LxA4 on antibiotic efficacy and the
combined effects on biofilm formation were also investigated. LxA4 and RvD2 reduced P. aeruginosa
biofilm formation and virulence gene expression. LxA4 increased ciprofloxacin inhibition on biofilm
formation but did not affect ciprofloxacin’s action on non-adherent bacteria. On the other hand, LxA4
increased bacterial killing action of imipenem but did not affect imipenem’s action on biofilm. We also
found that LxA4 can increase ciprofloxacin’s bacterial killing ability in established biofilm. Together these
results suggest that LxA4 has direct effects on P. aeruginosa biofilm formation and can increase antibiotic
efficacy directly.

LxA4 and RvD2 Reduce Two
Quorum-sensing Genes’ Expression

Fig. 4. Effects of SPMs on Pseudomonas aeruginosa quorum-sensing virulence gene expression. (a)
1/ΔCT of two virulence genes’ expression when treated with 1 nM LxA4. LxA4 significantly reduced
both genes’ expression at 4.5 hr. (b) 1/ΔCT of two virulence genes’ expression when treated with 1 nM
RvD2. RvD2 significantly reduced pqsA gene expression at 4.5 hr. Data are mean ± s.e.m., with p-values
determined by unpaired t-test comparing untreated control to treatment group of same timepoint. *
p < 0.05, ** p < 0.01. n = 3 independent experiments.

Specialized Pro-Resolving Mediators
Fig. 1. Chemical structures of specialized pro-resolving
mediators RvD1, RvD2, RvD5, and LxA4.
All three resolvins are 22C chains; RvD1 has hydroxyl groups at
C7, 8 and 17; RvD2 has hydroxyl groups at C7, 16 and 17; and
RvD5 has hydroxyl groups at C7 and 17. LxA4 is a 20C chain
with hydroxyl groups on C5, 6 and 15.

Fig. 6. LxA4 in combination with imipenem significantly decreased non-adherent cell growth but not biofilm
formation. Cultures were treated in a 96-well plate overnight with multiple concentrations of imipenem and
LxA4. The cultures and apical biofilm were washed away, and the remaining apical biofilm rings were stained
with 0.1% crystal violet. Absorbance was measured at 600 nm. Some cultures were recovered from a 96-well
plate, diluted and spread on tryptic soy agar plates to incubate overnight at 37°C. Colonies were counted the
next day. (a) LxA4 (10 nM) in combination with imipenem (0.1 μg/mL) significantly decreased non-adherent cell
growth. (b) LxA4 does not significantly affect the efficacy of imipenem against biofilm formation. These data
combined with the ciprofloxacin data (Fig. 4) suggests the synergistic action of LxA4 with antibiotics is
dependent on the class of antibiotics and their mechanism of action. CFU data are mean ± s.e.m. of percent
change from control adjusted to zero. Biofilm data are mean ± s.e.m. percent of control. * = p < 0.05; CFUs n = 4
independent experiments; biofilm n = 3 (LxA4 1 nM) and n = 4 (LxA4 10 nM) independent experiments.

RvD1 (C22H32O5)

LxA4
(C20H32O5)
RvD5 (C22H32O4)

LxA4 Does Not Affect Imipenem Efficacy
Against Biofilm Formation
But Enhances Suppression of Planktonic Growth
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RvD2 and LxA4 Reduce P. aeruginosa Biofilm Formation
Fig. 2. RvD2 and LxA4 reduce P. aeruginosa biofilm
formation. (a) In a 96-well plate, cultures were
treated with multiple concentrations of each SPM and
incubated at 37°C overnight. The cultures and apical
biofilm were washed away, and the remaining apical
biofilm rings were stained with 0.1% crystal violet.
Absorbance was measured at 600 nm. RvD2
significantly reduced biofilm formation at all
concentrations, with treatment at 0.1 nM less
effective than at 1 nM or 10 nM. LxA4 significantly
reduced biofilm formation, though 0.1 nM and 10 nM
were less effective than 1 nM. (b) Effects of FPR2
receptor peptide agonist on P. aeruginosa biofilm
formation. Cultures were treated with multiple
concentrations of the peptide agonist WKYMVm.
Peptide agonist WKYMVm did not significantly affect
the formation of biofilm at either concentration
tested. Data are mean ± s.e.m. of percent change
from control adjusted to zero. * = p < 0.05; ** = p <
0.01; n = 3 independent experiments for all
treatments.

Hypotheses: How LxA4 Can Assist
Antibiotics Against Biofilms
Biofilm Formation: LxA4 antagonizes the LasR
receptor, blocking the quorum-sensing autoinducer 3-OC12 HSL, reducing biofilm
formation. Antibiotics (ABX) are then able to
access the bacteria and kill them.

Established Biofilm: LxA4, as a lipid, can integrate
with the biofilm matrix, weakening its integrity.
This provides an opportunity for antibiotics (ABX)
to access the bacteria within the biofilm and kill
them.

Fig. 7. Effects of LxA4 on ciprofloxacin action in pre-formed biofilms. (a) LxA4 (1 nM) significantly increased the
efficacy of ciprofloxacin (0.5 μg/mL) to reduce the amount of metabolically active bacterial cells associated
with the biofilm, determined by MTT assay. (b) LxA4 does not significantly alter the efficacy of ciprofloxacin to
reduce biofilm biomass, determined by crystal violet staining. This suggests that LxA4 treatment can aid the
ciprofloxacin in accessing the bacteria associated with a pre-formed biofilm. Viability data are mean ± s.e.m. of
percent change from control adjusted to zero. Biofilm data are mean ± s.e.m. percent of control. * = p < 0.05;
viability n = 5 independent experiments; biomass n = 5 independent experiments.

LxA4 Enhances Ciprofloxacin Effects on Biofilm
Formation But Has No Affect on Planktonic Cell Growth

Conclusions

Non-adherent cell growth of P. aeruginosa was
unaffected by LxA4 or RvD2

Fig. 3. Non-adherent cell growth of P. aeruginosa was unaffected by LxA4 or RvD2. SPMs were added to P.
aeruginosa cultures in 96-well plates and incubated with orbital shaking at 37°C in a microplate reader for
15 hr. Absorbance was measured every 10 min. Neither LxA4 (a) nor RvD2 (b) showed any significant effect
on non-adherent cell growth in minimal media. n = 3 (LxA4) and n = 4 (RvD2) independent experiments.

LxA4 Can Increase the Efficacy of Ciprofloxacin
Against Bacteria of an Established Biofilm

In summary, our results show that LxA4 and RvD2 can directly reduce P. aeruginosa biofilm formation. LxA4 and
RvD2 can also downregulate virulence gene expression. LxA4 enhances the efficacy of antibiotics directly against
P. aeruginosa biofilm formation and bacterial cells within existing biofilm. These studies also provide evidence
that further investigation into the antimicrobial mechanisms of RvD2 is warranted. The results suggest that there
is relative selectivity in SPM inhibition of biofilm formation.
Fig. 5. LxA4 treatment can aid the efficacy of the antibiotic ciprofloxacin in reducing biofilm
formation. Cultures were treated in a 96-well plate overnight with multiple concentrations of
ciprofloxacin and LxA4. The cultures and apical biofilm were washed away, and the remaining apical
biofilm rings were stained with 0.1% crystal violet. Absorbance was measured at 600 nm. Some
cultures were recovered from the 96-well plate, diluted and spread on tryptic soy agar plates to
incubate overnight at 37°C. Colonies were counted the next day. (a) LxA4 does not have an effect
when combined with ciprofloxacin on non-adherent cell growth, determined by colony forming
units (CFUs). (b) When combined with LxA4, biofilm formation is significantly reduced in
ciprofloxacin treatments at and above bactericidal doses (0.5 μg/mL). CFU data are mean ± s.e.m.
of percent change from control adjusted to zero. Biofilm data are mean ± s.e.m. percent of control.
** = p < 0.01; CFUs n = 4 independent experiments; biofilm n = 6 (1 nM) and n = 3 (10 nM)
independent experiments.

Future Directions
• SPM treatment of P. aeruginosa to evaluate the effects of SPMs on quorum-sensing gene expression and
regulation
• 2-hit treatments of SPMs ± antibiotics on established biofilms to assess the effects of SPMs on antibiotic
ability to kill biofilm-associated persister cells
• Pre-treatment of THP-1 monocytes with SPMs against established biofilm
• Co-incubation of THP-1 monocytes with SPMs against established biofilm to assess the effects of SPMs on
immune cell ability to phagocytose biofilm
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